Nab-paclitaxel regimen active in locally advanced cervical cancer
The addition of nab-paclitaxel to cisplatin-based concurrent chemoradiotherapy appeared effective for women with locally advanced cervical cancer, according to prospective study results.The combination also appeared well tolerated, findings presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer showed.
Source: healio.com